- Business Type:
- Manufacturer
- Year Established:
- 2006
- Total Revenue:
- US$1 Million - US$2.5 Million
- Main Markets:
- North America, South America, Eastern Europe, Southeast Asia, Africa, Mid East, Eastern Asia, Western Europe
Company Description
Chengdu Sino-Strong Pharmaceutical Co., Ltd. is a high-tech enterprise, located in Wenjiang Cross-straits Technological Industry Park that is a national level development zone, we specialized in the new drugs research, the manufacture of new APIs, and pharmaceutical raw materials and intermediates.
The company consists of R&D Center, Production Center, Testing Center and Marketing Center. There are a lot of senior researchers, including doctors and professors of organic chemistry in our R&D Center. Our company has the advanced technology in the multi-step synthesis and the new route development of self-intellectual property rights.
We have good collaborative relations with many famous colleges and institutes, and with many famous pharmaceutical and fine chemicals company in I&E trade and commercial production. Our products are well recognized by customers around the world.
Sino-storg"s core business:
Rocuronium Bromide EP6.0, Vecuronium Bromide, Pancuronium Bromide, Pipecuronium Bromide, Fasudil hydrochloride, Palonosetron Hydrochloride, Dolasetron Mesylate USP3.0, Darifenacin Hydrobromide, Solifenacin, Mitiglinide calcium, Zofenopril Calcium and their intermediates Custom Chemical Synthesis.